KRISTEN BUROCK: Open Payments
NPI 1467939371 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 60 payments from 11 companies in 2025. Trend: 2023 $1,443 · 2024 $807 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $271 |
| AstraZeneca Pharmaceuticals LP | 12 | $221 |
| Electromed, Inc. | 13 | $158 |
| JAZZ PHARMACEUTICALS INC. | 4 | $91 |
| Verona Pharma, Inc. | 4 | $84 |
| United Therapeutics Corporation | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
Products named: NUCALA, SMARTVEST, XYWAV, FASENRA, Ohtuvayre, BREZTRI, DUPIXENT, Tyvaso.
Industry payments across OH — which companies pay providers there.
